**Question:** True for lithium:-

**Core Concept**
Lithium is a mood stabilizer used in the management of bipolar disorder, primarily by modulating the activity of neurotransmitters such as serotonin and dopamine. Its pharmacological effects are closely related to its ability to inhibit the enzyme glycogen synthase kinase-3 (GSK-3).

**Why the Correct Answer is Right**
Lithium's mechanism of action involves the inhibition of GSK-3, which is a key regulator of glycogen synthesis and neuronal survival. By inhibiting GSK-3, lithium increases the activity of glycogen synthase, thereby promoting glycogen synthesis. Additionally, lithium's inhibition of GSK-3 has been shown to have neuroprotective effects, potentially contributing to its therapeutic efficacy in bipolar disorder.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as lithium's primary mechanism of action does not involve direct modulation of the dopaminergic system.
**Option B:** This option is incorrect as lithium's effects on the thyroid axis are complex and multifaceted, but its primary use is not for thyroid disorders.
**Option C:** This option is incorrect as lithium's effects on the renal system are primarily related to its potential to cause nephrogenic diabetes insipidus, rather than its primary mechanism of action.

**Clinical Pearl / High-Yield Fact**
Lithium's narrow therapeutic index and potential for toxicity emphasize the importance of regular monitoring of serum lithium levels in patients receiving this medication.

**Correct Answer:** D. [Insert correct answer text here]